Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 90

Comparing two collagen membranes for dental implant bone augmentation

Official title: A Randomized Controlled Clinical Trial to Compare Two Collagen Membranes for Guided Bone Regeneration (GBR) Around Dental Implants Restored with Monolithic Zirconia Single Crowns Using Three Different Veneering Designs

Run by University of Geneva, Switzerland · NCT06724783 · Data updated 2026-11-12

This study tests whether a new type of collagen membrane can help improve bone stability better than a standard one for people getting dental implants to replace a single tooth.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment68 (estimated)
SponsorUniversity of Geneva, Switzerland
Academic / other
Locations1 site (Geneva, Canton of Geneva)
StatusRecruiting
StartedJune 30, 2023
Main results expectedJune 30, 2030
Study endsSeptember 30, 2030
Registry record updatedDecember 9, 2024
Trial IDNCT06724783 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who require an implant-supported crown in the aesthetic region and can undergo a one-stage bone augmentation procedure.

Probably not a fit

Patients with large bone defects requiring a two-stage augmentation procedure or those with allergies to collagen or implant materials may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effectiveness of two types of collagen membranes used during bone augmentation procedures for dental implants. Participants will receive an implant with simultaneous bone augmentation and will be monitored for bone stability and the occurrence of ceramic restoration chipping over a period of five years. The study will evaluate whether a new compressed collagen membrane provides better bone stability compared to a standard membrane. The trial focuses on patients needing a single tooth replacement in the aesthetic zone.

Why it matters

Potential benefit: If successful, this study could lead to improved outcomes in bone stability and reduced complications for patients receiving dental implants.

How similar studies have gone: Previous studies have shown promising results with guided bone regeneration techniques, but the specific comparison of these two collagen membranes is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Informed Consent signed by the subject
* ≥18 years of age
* No active periodontal disease
* Full-mouth plaque score and full-mouth bleeding score \<25%.
* Patients in need of an implant-supported crown at a single-tooth gap in the aesthetic region: 11-15, 21-25, 31-35, 41-45 (FDI)
* Patients in need of GBR during implant placement (1-stage procedure)
* Presence of mesial and distal natural teeth or implant
* Implant placement at least 6 weeks after tooth extraction
* No need for soft tissue grafting

Exclusion Criteria:

* Any conditions or circumstances which would interfere with the requirements for oral surgery
* Patients with large bone defects, in need of a primary bone augmentation (two-stage procedure)
* Allergy to any implant metallic component
* Allergy to collagen
* Previous oral-maxillo-facial radiotherapy
* Any disorders in the planned implant area such as previous tumors, chronic bone
* disease (such as rheumatoid disease)
* Any ongoing application of interfering medication (steroid therapy, bisphosphonate, etc.)
* Alcohol or drug abuse
* No need for soft tissue grafting
* Patients with inadequate oral hygiene or persistent oral infection
* Clinically significant concomitant diseases (e.g. renal failure, hepatic disfunction, cardiovascular diseases)
* Heavy smokers (\>10 cigarettes/day)
* Uncontrolled diabetes
* Severe bruxism or other destructive habits
* Pregnant or lactating women

Where it's running

  • University of Geneva
    Geneva, Canton of Geneva, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Malin Strasding, Dr dent med — University Clinic of Dental Medicine, University of Geneva
  • Study coordinator: Malin Strasding, Dr dent med
  • Email: malin.strasding@unige.ch
  • Phone: +41 (0)22 379 40 50

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.